TrademarkDir
GENTITAN
DEAD

Serial Number

79369107

Owner

Nanjing Genscript Biotech Co., Ltd.

Attorney

YUE ROBERT XU

Filing Date

Mar 15, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

GENTITAN Trademark

Serial Number: 79369107

GENTITAN is a trademark filed by Nanjing Genscript Biotech Co., Ltd. on March 15, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Nanjing Genscript Biotech Co., Ltd.

No. 28 Yongxi Road,
Jiangsu Province 211100 , CN

Entity Type: 03

Trademark Details

Filing Date

March 15, 2023

Registration Date

Not Registered

Published for Opposition

September 19, 2023

Goods & Services

Technology research in the field of gene synthesis; technology research in the field of gene editing; technology research in the field of DNA chips; research and development of new products for others; scientific laboratory services; medical and scientific research, namely, conducting clinical trials for others; structural and functional analysis of genomes; medical research; medical laboratory services; stem cell research services; research and development services in the field of antibodies; research in the field of physics; biological research and analysis; bacteriological research and analysis; genetic testing for scientific research purposes; biotechnology research; testing of pharmaceuticals; DNA screening for scientific research purposes; biomedical research services; biological cloning services

Filing History

OPPOSITION TERMINATED NO. 999999
Feb 23, 2026 OP.T
OPPOSITION SUSTAINED NO. 999999
Feb 23, 2026 OP.S
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 3, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 3, 2025 ABN2
REFUSAL PROCESSED BY IB
May 24, 2025 RFNT
IRREGULARITY ON REFUSAL FROM IB
Apr 30, 2025 IRRF
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 18, 2025 RFCS
REFUSAL PROCESSED BY MPU
Apr 18, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 18, 2025 RFCR
NON-FINAL ACTION WRITTEN
Apr 17, 2025 CNRT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Mar 17, 2025 JURT
LETTER OF PROTEST EVIDENCE REVIEWED - ACTION TAKEN
Mar 17, 2025 LOPE
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 26, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 9, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 9, 2024 OPNR
REFUSAL PROCESSED BY IB
Feb 6, 2024 RFNP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 2, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 2, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 2, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 2, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 2, 2024 COAR
OPPOSITION INSTITUTED NO. 999999
Jan 25, 2024 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Jan 18, 2024 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Jan 18, 2024 OPNC
OPPOSITION PAPERS RECEIVED AT TTAB
Jan 17, 2024 OPPF
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Oct 12, 2023 JURT
EXTENSION OF TIME TO OPPOSE RECEIVED
Oct 5, 2023 ETOF
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sep 26, 2023 ZZZX
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Sep 25, 2023 JURT
LETTER OF PROTEST EVIDENCE FORWARDED
Sep 21, 2023 LOPT
PUBLISHED FOR OPPOSITION
Sep 19, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Sep 18, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 30, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 30, 2023 OP2R
NOTICE OF PUBLICATION
Aug 30, 2023 NPUB
NEW REPRESENTATIVE AT IB RECEIVED
Aug 25, 2023 NREP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 16, 2023 CNSA
ASSIGNED TO EXAMINER
Aug 15, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
May 23, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 17, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 16, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 11, 2023 REPR

Related Trademarks

More from this Owner

SUREPAGE logo

SUREPAGE